The new AI Document Creation tool generates professional contracts, policies, proposals and reports from simple prompts in seconds—no templates or blank-page starts requiredBOSTON, Dec. 10, 2025 ...

AFTER AMERICA, China is the world’s largest developer of new medicines. Its companies ran nearly a third of the planet’s clinical trials last year. That is up from just 5% a decade before (see chart 1 ...

A federal judge officially approved drugmaker Purdue Pharma's $7.4 billion deal to settle thousands of lawsuits over the toll of the opioid epidemic and pay victims, prosecutors in the case told USA ...

Under the plan, the company will dissolve and its owners, members of the Sackler family, will pay as much as $7 billion of their personal fortune to states, localities, tribes and others harmed in the ...

Bit by bit, HR is taking over corporate life. The ranks of human-resources professionals across the rich world are swelling. Their roles are expanding. And some are still insisting that you complete ...

In today’s 2-Minute Tech Briefing, SAP announces a major HR platform overhaul with AI-driven SmartRecruiters integration. Cisco issues an urgent warning on optical hardware reliability impacting large ...

The administration hopes to make the TrumpRx website available in early 2026. While President Donald Trump announced on Tuesday that Pfizer, one of the leading pharmaceutical companies, had agreed to ...

In May 2025, the Trump administration issued an executive order titled “Regulatory Relief to Promote Domestic Production of Critical Medicines” directing the Food and Drug Administration (FDA) and the ...

President Trump’s new pharmaceutical tariff policy throws another wrench into an already increasingly complex drug supply chain, with experts calling for more clarity and details into the White ...

The biopharma industry has spent much of this year grappling with fast-moving changes related to the Trump administration's trade policies. On Thursday, without warning, came another jolt. “Starting ...

President Donald Trump announced Thursday that brand-name or patented pharmaceutical products will be subject to a 100% tariff starting October 1 – unless the drugmaker is building a manufacturing ...